Literature DB >> 21357720

Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.

Stephanie P Jehl1, Amy M Doling, Kara S Giddings, Armelle Phalipon, Philippe J Sansonetti, Marcia B Goldberg, Michael N Starnbach.   

Abstract

CD8(+) T lymphocytes often play a primary role in adaptive immunity to cytosolic microbial pathogens. Surprisingly, CD8(+) T cells are not required for protective immunity to the enteric pathogen Shigella flexneri, despite the ability of Shigella to actively secrete proteins into the host cytoplasm, a location from which antigenic peptides are processed for presentation to CD8(+) T cells. To determine why CD8(+) T cells fail to play a role in adaptive immunity to S. flexneri, we investigated whether antigen-specific CD8(+) T cells are primed during infection but are unable to confer protection or, alternatively, whether T cells fail to be primed. To test whether Shigella is capable of stimulating an antigen-specific CD8(+) T-cell response, we created an S. flexneri strain that constitutively secretes a viral CD8(+) T-cell epitope via the Shigella type III secretion system and characterized the CD8(+) T-cell response to this strain both in mice and in cultured cells. Surprisingly, no T cells specific for the viral epitope were stimulated in mice infected with this strain, and cells infected with the recombinant strain were not targeted by epitope-specific T cells. Additionally, we found that the usually robust T-cell response to antigens artificially introduced into the cytoplasm of cultured cells was significantly reduced when the antigen-presenting cell was infected with Shigella. Collectively, these results suggest that antigen-specific CD8(+) T cells are not primed during S. flexneri infection and, as a result, afford little protection to the host during primary or subsequent infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357720      PMCID: PMC3088127          DOI: 10.1128/IAI.00939-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens.

Authors:  J Karttunen; S Sanderson; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  Salmonella inhibit T cell proliferation by a direct, contact-dependent immunosuppressive effect.

Authors:  Adrianus W M van der Velden; Michael K Copass; Michael N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

Review 3.  Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.

Authors:  P Sansonetti; A Phalipon
Journal:  Res Immunol       Date:  1996 Oct-Dec

4.  CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.

Authors:  S P Fling; R A Sutherland; L N Steele; B Hess; S E D'Orazio; J Maisonneuve; M F Lampe; P Probst; M N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin.

Authors:  J D Ballard; A M Doling; K Beauregard; R J Collier; M N Starnbach
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  Disease-dependent changes in T-cell populations in patients with shigellosis.

Authors:  D Islam; B Christensson
Journal:  APMIS       Date:  2000-04       Impact factor: 3.205

7.  A systemic downregulation of gamma interferon production is associated with acute shigellosis.

Authors:  R Raqib; A Gustafsson; J Andersson; M Bakhiet
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

8.  Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.

Authors:  M L Bernardini; J Mounier; H d'Hauteville; M Coquis-Rondon; P J Sansonetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid.

Authors:  A T Maurelli; B Blackmon; R Curtiss
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells.

Authors:  R Ménard; P J Sansonetti; C Parsot
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

View more
  5 in total

1.  Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes.

Authors:  Laurie Pinaud; Fatoumata Samassa; Ziv Porat; Mariana L Ferrari; Ilia Belotserkovsky; Claude Parsot; Philippe J Sansonetti; François-Xavier Campbell-Valois; Armelle Phalipon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

2.  Shigella impairs T lymphocyte dynamics in vivo.

Authors:  Wilmara Salgado-Pabón; Susanna Celli; Ellen T Arena; Katharina Nothelfer; Pascal Roux; Gernot Sellge; Elisabetta Frigimelica; Philippe Bousso; Philippe J Sansonetti; Armelle Phalipon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-15       Impact factor: 11.205

Review 3.  Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population.

Authors:  Ahmad Nasser; Mehrdad Mosadegh; Taher Azimi; Aref Shariati
Journal:  Mol Cell Pediatr       Date:  2022-06-19

Review 4.  Shigella manipulates host immune responses by delivering effector proteins with specific roles.

Authors:  Hiroshi Ashida; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Front Immunol       Date:  2015-05-07       Impact factor: 7.561

5.  IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I.

Authors:  Stephanie P Jehl; Catarina V Nogueira; Xuqing Zhang; Michael N Starnbach
Journal:  PLoS Pathog       Date:  2012-08-09       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.